navepegritide (Yuviwel)

Indications

• dwarfiam due to achondroplasia

Dosage

• once weekly injection

Mechanism of action

• provides sustained exposure to C-type natriuretic peptide, which counters growth-limiting effects driven by the FGFR3 mutation in achondroplasia

More general terms

• metabolic agent (metabolic modifier)